FL Clinical Trials

1,656 recruitingLast updated: July 25, 2026

There are 1,656 actively recruiting fl clinical trials across 100 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


FL Trials at a Glance

1,656 actively recruiting trials for fl are listed on ClinicalTrialsFinder across 6 cities in 100 countries. The largest study group is Not Applicable with 651 trials, with the heaviest enrollment activity in New York, Boston, and Houston. Lead sponsors running fl studies include National Institute of Allergy and Infectious Diseases (NIAID), Mayo Clinic, and Assistance Publique - Hôpitaux de Paris.

Treatments under study

About FL Clinical Trials

Looking for clinical trials for FL? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new FL trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about FL clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,656 trials

Recruiting
Phase 4

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

Chronic Obstructive Pulmonary DiseaseHyperinflation
AstraZeneca56 enrolled7 locationsNCT07073950
Recruiting
Phase 1

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Systemic SclerosisIdiopathic Inflammatory MyopathySystemic Lupus Erythematosus (With and Without Nephritis)
Allogene Therapeutics66 enrolled14 locationsNCT07085104
Recruiting
Phase 1

pH1N1 Blinded Challenge Study

Influenza
National Institute of Allergy and Infectious Diseases (NIAID)90 enrolled2 locationsNCT07110532
Recruiting
Not Applicable

Long-Term Effects of Walnut Consumption on Brain Function

HealthyCognitive DeclineAbdominal Obesity+6 more
Maastricht University Medical Center55 enrolled1 locationNCT07422220
Recruiting
Phase 2

BPL-1357 Against H1N1 Influenza Virus Challenge

HumanInfluenza
National Institute of Allergy and Infectious Diseases (NIAID)129 enrolled2 locationsNCT07215858
Recruiting

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

Trisomy 8 MosaicismTrisomy 8 Associated Autoinflammatory DiseaseMucosal Ulcerations
National Institute of Allergy and Infectious Diseases (NIAID)750 enrolled1 locationNCT07683104
Recruiting
Not Applicable

Internet Based Psychological Support

DepressionStressConflict Resolution
Dartmouth-Hitchcock Medical Center500 enrolled1 locationNCT02726061
Recruiting
Phase 1

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma ( FL)Mantle Cell Lymphoma (MCL)+2 more
LTZ Therapeutics, Inc.42 enrolled6 locationsNCT07121946
Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Genetic diseasesFeverROSAH+4 more
National Human Genome Research Institute (NHGRI)5,000 enrolled5 locationsNCT00001373
Recruiting
Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Rheumatoid ArthritisSystemic Lupus ErythematosusIdiopathic Inflammatory Myopathies
AstraZeneca72 enrolled37 locationsNCT06916806
Recruiting
Phase 3

Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers

Radiotherapy, AdjuvantOral Cavity CarcinomaFlap+1 more
Centre Francois Baclesse348 enrolled30 locationsNCT06798922
Recruiting
Not Applicable

Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

Inflammatory Bowel Diseases
University of Michigan40 enrolled1 locationNCT06188793
Recruiting
Not Applicable

Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
University of Michigan40 enrolled1 locationNCT07456566
Recruiting
Not Applicable

GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes

Type 1 Diabetes Mellitus (T1DM)Hypoglycemia (Diabetic)Diabetes Distress+1 more
Shifa International Hospital110 enrolled1 locationNCT07726680
Recruiting
Phase 1

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

SLE (Systemic Lupus)Diffuse Cutaneous Systemic SclerosisSystemic Sclerosis+4 more
CRISPR Therapeutics80 enrolled14 locationsNCT06925542
Recruiting
Not Applicable

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

Esophageal AdenocarcinomaBarrett EsophagusGastroesophageal Reflux
Case Comprehensive Cancer Center800 enrolled5 locationsNCT06687603
Recruiting
Phase 1

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Influenza PreventionSeasonal Influenza
National Institute of Allergy and Infectious Diseases (NIAID)45 enrolled1 locationNCT06863142
Recruiting
Phase 1

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID)56 enrolled1 locationNCT07111078
Recruiting

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Acute Myeloid Leukaemia (AML)Follicular Lymphoma ( FL)
Tempus AI550 enrolled9 locationsNCT07154823
Recruiting

Host-microbiota Interactions in Auto-inflammatory Diseases

Autoinflammatory Diseases
Assistance Publique - Hôpitaux de Paris300 enrolled1 locationNCT07718555